Accordant Group (AGL) Scheme meeting 2026 summary
Event summary combining transcript, slides, and related documents.
Scheme meeting 2026 summary
16 Apr, 2026Opening remarks and agenda
Meeting opened with board, CEO, and quorum present, emphasizing high shareholder support and providing instructions for online participation, voting, and Q&A.
Purpose was to allow shareholders to ask questions and clarify the capital raise process.
Financial performance review
Trading conditions have been challenging, but FY26 is estimated to show improved trading and year-on-year earnings growth in blue-collar and executive recruitment segments.
Group EBITDA (pre IFRS-16) is projected to return to positive in FY26, with further improvement expected in FY27 and FY28.
Revenue growth forecasts of 20% per annum for the next two years are based on detailed business unit analysis, though risks remain due to economic uncertainty.
Net debt is estimated to fall from $30.5m at 31 March 2026 to $19.7m by end of FY28, assuming a successful capital raise.
Board and executive committee updates
Board, CEO, Chairman, majority shareholder, and senior management have committed to participating in the rights offer, demonstrating confidence in the business.
The board evaluated multiple alternatives for capital raising and concluded this was the best option for shareholders.
Latest events from Accordant Group
- Revenue fell 22% with a $2.9M loss; no dividend, but strategic focus and AI adoption continue.AGL
AGM 20253 Feb 2026 - Revenue and profit fell, but all board resolutions passed with strong shareholder support.AGL
AGM 202419 Jan 2026 - Revenue down 8% but losses narrowed; cash flow, debt, and segment performance improved.AGL
H1 202610 Nov 2025 - Revenue down 21% and net loss of $1.44m, but cost controls and investments support recovery.AGL
H1 202513 Jun 2025 - Net loss narrowed to $(2.9)m on 22% lower revenue, with recovery expected to be slow.AGL
H2 20259 Jun 2025